目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Genetic Toxicology Testing Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Genetic Toxicology Testing Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. Genetic Toxicology Testing Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Genetic Toxicology Testing Market: Product Movement Analysis, USD Million, 2023 & 2030
4.3. Reagents & Consumables
4.3.1. Reagents & Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Assays Kit
4.4.1. Assays Kit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Services
4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Genetic Toxicology Testing Market: Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Genetic Toxicology Testing Market: Type Movement Analysis, USD Million, 2023 & 2030
5.3. In vitro
5.3.1. In vitro Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. In vivo
5.4.1. In vivo Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Genetic Toxicology Testing Market: Assay Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Genetic Toxicology Testing Market: Assay Movement Analysis, USD Million, 2023 & 2030
6.3. Comet Assay
6.3.1. Comet Assay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Micronucleus Assay
6.4.1. Micronucleus Assay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Chromosomal Aberration Test
6.5.1. Chromosomal Aberration Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Genetic Mutation Test
6.6.1. Genetic Mutation Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Genetic Toxicology Testing Market: Application Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Genetic Toxicology Testing Market: Application Movement Analysis, USD Million, 2023 & 2030
7.3. Pharmaceutical & biotechnology
7.3.1. Pharmaceutical & biotechnology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Food Industry
7.4.1. Food Industry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Cosmetics Industry
7.5.1. Cosmetics Industry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Other
7.6.1. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Genetic Toxicology Testing Market: Regional Estimates & Trend Analysis
8.1. Genetic Toxicology Testing Market Share, By Region, 2023 & 2030, USD Million
8.2. North America
8.2.1. North America Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. UK.
8.3.2.1. UK Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. France Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Italy Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Spain Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Denmark Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Sweden Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Norway Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Japan Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. China
8.4.3.1. China Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. India Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. Australia
8.4.5.1. Australia Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.6. South Korea
8.4.6.1. South Korea Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Thailand Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. UAE Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Thermo Fisher Scientific, Inc.
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Charles River Laboratories
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. Laboratory Corporation of America Holdings
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. Eurofins Scientific
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Jubilant Ingrevia Limited.
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. Syngene International Limited
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. Gentronix, Inotiv
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. Creative Bioarray
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. MB Research Laboratories
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives